Nyxoah SA
XBRU:NYXH

Watchlist Manager
Nyxoah SA Logo
Nyxoah SA
XBRU:NYXH
Watchlist
Price: 7.9 EUR -0.75%
Market Cap: 271.4m EUR
Have any thoughts about
Nyxoah SA?
Write Note

Nyxoah SA
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nyxoah SA
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Nyxoah SA
XBRU:NYXH
Net Income
-€44.7m
CAGR 3-Years
-54%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Biocartis Group NV
XBRU:BCART
Net Income
-€67.9m
CAGR 3-Years
-1%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Ion Beam Applications SA
XBRU:IBAB
Net Income
-€9.1m
CAGR 3-Years
N/A
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Sequana Medical NV
XBRU:SEQUA
Net Income
-€27.2m
CAGR 3-Years
-8%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
No Stocks Found

Nyxoah SA
Glance View

Market Cap
271.7m EUR
Industry
Health Care

Nyxoah SA engages in the research and development, manufacture and sale of medical devices. The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 72 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

NYXH Intrinsic Value
3.53 EUR
Overvaluation 55%
Intrinsic Value
Price

See Also

What is Nyxoah SA's Net Income?
Net Income
-44.7m EUR

Based on the financial report for Dec 31, 2023, Nyxoah SA's Net Income amounts to -44.7m EUR.

What is Nyxoah SA's Net Income growth rate?
Net Income CAGR 5Y
-38%

Over the last year, the Net Income growth was -49%. The average annual Net Income growth rates for Nyxoah SA have been -54% over the past three years , -38% over the past five years .

Back to Top